Masahisa Yamane

Showing 1-4 of 4 articles

EuroCTO Club 2018 meeting: “Experts Live” in Toulouse

Boudou N, Avran A, Garbo R, Lefèvre T, Hildick-Smith D, Reifart N, Galassi A, Mattesini A, Dini C, Brilakis E, Yamane M, Sianos G, Mashayekhi K, Karmpaliotis D, DeMartini T, Werner G, Di Mario C

April 5, 2019 | 10.4244/EIJV14I18A319

Coronary interventions

Incidence and impact on midterm outcome of intimal versus subintimal tracking with both antegrade and retrograde approaches in patients with successful recanalisation of chronic total occlusions: J-PROCTOR 2 study

Hasegawa K, Tsuchikane E, Okamura A, Fujita T, Yamane M, Oikawa Y, Suzuki Y, Igarashi Y, Kyo E, Muramatsu T

February 3, 2017 | 10.4244/EIJ-D-16-00557

Contemporary retrograde approach for the recanalisation of coronary chronic total occlusion: on behalf of the Japanese Retrograde Summit Group

Yamane M, Muto M, Matsubara T, Nakamura S, Muramatsu T, Oida A, Igarashi Y, Nozaki Y, Kijima M, Tuschikane E

May 21, 2013 | 10.4244/EIJV9I1A15

Primary stenting for left-main shock syndrome

Yamane M, Inoue S, Yamane A, Kinebuchi O, Yokozuka H

August 20, 2005

1

Latest news

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?

Michael Foley et al.

September 20, 2021

Valvular disease